ReviewFrontiers in immunology2026
Research progress on the roles of extracellular vesicles in tumor immunity and drug resistance.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) have emerged as pivotal mediators of intercellular communication and have attracted considerable scientific interest in recent years owing to their critical roles in tumor immunity and drug resistance. This review offers a comprehensive overview of the mechanisms by which EVs function within the tumor microenvironment, focusing on their involvement in immune evasion, tumor progression, and the development of resistance to therapeutic agents. By summarizing recent research advances, this review highlights the potential of EVs as diagnostic biomarkers and therapeutic targets and emphasizes their significance in improving treatment efficacy and overcoming clinical resistance. This review also outlines future research directions to clarify the multifaceted roles of EVs in cancer biology and facilitate the development of novel therapeutic approaches to enhance patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.